Literature DB >> 27893998

Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections.

Andrea Granados1, Adriana Peci2, Allison McGeer3, Jonathan B Gubbay4.   

Abstract

BACKGROUND: The role of viral load in respiratory viral infection is unclear. It is proposed that the viral load of some, but not all respiratory viruses correlate with disease severity.
OBJECTIVES: We aimed to determine if an association exists between viral loads among patients in ambulatory settings, compared to those requiring hospitalization/intensive care unit (ICU) admission with influenza A/H3N2, influenza B, or human rhinovirus (HRV); we also explored the impact of age, gender and co-detection of Streptococcus pneumoniae on patient setting. We hypothesized that hospitalized/ICU patients have higher respiratory virus viral loads compared to ambulatory (e.g. walk-in clinics, family practices)/ER patients. STUDY
DESIGN: We quantified viral load by in-house real-time RT-PCR in 774 nasopharyngeal swabs with influenza A/H3N2, or B or HRV viruses from various patient settings in Ontario, Canada.
RESULTS: Mean viral load (log10 copies/ml) of influenza A/H3N2 (6.94) was higher than influenza B (4.96) and HRV (5.58) (p<0.0001). Influenza A/H3N2 viral loads were highest in infants and the elderly; however, increased A/H3N2 viral loads were not associated with hospitalization/ICU admission compared to swabs collected in ambulatory/ER settings. Influenza B viral loads were higher in patients in hospital/ICU settings compared to those in ambulatory settings (OR 1.28, 95% CI 1.11-1.47). HRV viral loads did not differ by age (p=0.67) or setting (p=0.54); there was no association between S. pneumoniae colonization and setting for any virus.
CONCLUSION: When compared to ambulatory/ER patients, viral load was higher in hospitalized/ICU patients with influenza B, but not influenza A or HRV.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disease severity; Influenza A; Influenza B; RT-qPCR; Rhinovirus; Viral load

Mesh:

Year:  2016        PMID: 27893998     DOI: 10.1016/j.jcv.2016.11.008

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  30 in total

1.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

2.  Influenza B viral load analysis in patients with acute respiratory infection from a tertiary hospital in Brazil.

Authors:  Vitória Rodrigues Guimarães Alves; Luciano Kleber de Souza Luna; Jessica Santiago Cruz; Ana Helena Perosa; Nancy Bellei
Journal:  J Med Virol       Date:  2019-12-09       Impact factor: 2.327

Review 3.  Interim Guidelines on Antiviral Therapy for COVID-19.

Authors:  Sun Bean Kim; Kyungmin Huh; Jung Yeon Heo; Eun Jeong Joo; Youn Jeong Kim; Won Suk Choi; Yae Jean Kim; Yu Bin Seo; Young Kyung Yoon; Nam Su Ku; Su Jin Jeong; Sung Han Kim; Kyong Ran Peck; Joon Sup Yeom
Journal:  Infect Chemother       Date:  2020-04-23

4.  Gemykibivirus Genome in Lower Respiratory Tract of Elderly Woman With Unexplained Acute Respiratory Distress Syndrome.

Authors:  Jian Wang; Yanpeng Li; Xi He; Jinmin Ma; Wenxin Hong; Fengyu Hu; Lingzhai Zhao; Qiongfang Li; Jianhui Zhang; Chiyu Zhang; Fuchun Zhang
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

5.  Prospective evaluation of diagnostic tools for respiratory viruses in children and adults.

Authors:  L Busson; M Bartiaux; S Brahim; D Konopnicki; N Dauby; M Gérard; P De Backer; K Van Vaerenbergh; B Mahadeb; M De Foor; M Wautier; O Vandenberg; P Mols; J Levy; M Hallin
Journal:  J Virol Methods       Date:  2019-01-15       Impact factor: 2.014

6.  Rapid multiplex PCR assays in patients with respiratory viral infections: is semi-quantitative data useful? A pilot study.

Authors:  Pierre Gazeau; Sophie Vallet; Séverine Ansart; Clémence Beauruelle; Adissa Tran-Minoui; Christopher Payan; Léa Pilorgé
Journal:  Braz J Microbiol       Date:  2021-06-09       Impact factor: 2.476

7.  COVID-19 viral load not associated with disease severity: findings from a retrospective cohort study.

Authors:  Abdulkarim Abdulrahman; Saad I Mallah; Manaf Alqahtani
Journal:  BMC Infect Dis       Date:  2021-07-16       Impact factor: 3.090

8.  Successes and Failures of the Live-attenuated Influenza Vaccine: Can We Do Better?

Authors:  Laura Matrajt; M Elizabeth Halloran; Rustom Antia
Journal:  Clin Infect Dis       Date:  2020-03-03       Impact factor: 9.079

9.  Fomite-mediated transmission as a sufficient pathway: a comparative analysis across three viral pathogens.

Authors:  Alicia N M Kraay; Michael A L Hayashi; Nancy Hernandez-Ceron; Ian H Spicknall; Marisa C Eisenberg; Rafael Meza; Joseph N S Eisenberg
Journal:  BMC Infect Dis       Date:  2018-10-29       Impact factor: 3.090

10.  Comparative Transcriptomic and Metagenomic Analyses of Influenza Virus-Infected Nasal Epithelial Cells From Multiple Individuals Reveal Specific Nasal-Initiated Signatures.

Authors:  Kai Sen Tan; Yan Yan; Wai Ling Hiromi Koh; Liang Li; Hyungwon Choi; Thai Tran; Richard Sugrue; De Yun Wang; Vincent T Chow
Journal:  Front Microbiol       Date:  2018-11-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.